TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17470584

Group type: EXPERIMENTAL
Intervention: Daily Record of Severity of Problems (DRSP) scores using the standard method
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Daily Record of Severity of Problems (DRSP) scores using the alternative method
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Abbreviated seven-item DRSP version
Number of subjects: 697
Study: 14709941

Group type: EXPERIMENTAL
Intervention: Milnacipran
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 0
Study: 11488789

Group type: EXPERIMENTAL
Intervention: Ranitidine alone
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Quadruple therapy (ranitidine, colloidal bismuth subcitrate, metronidazole, and tetracycline)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 262
Study: 9873262

Group type: EXPERIMENTAL
Intervention: Fresh platelets tested within 4 hours of collection
Number of subjects: 48

Group type: COMPARATOR
Intervention: Stored platelets (5 days at 22 degrees C)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Platelets frozen at -70 degrees C in 5% DMSO
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Lyophilized platelets
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Platelets frozen at -70 degrees C without cryoprotectants
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Platelets stored at 4 degrees C
Number of subjects: 48
Study: 7974072

Group type: EXPERIMENTAL
Intervention: 250 mg trospectomycin sulfate i.m.
Number of subjects: 95

Group type: COMPARATOR
Intervention: 250 mg ceftriaxone i.m.
Number of subjects: 95
Study: 3179203

Group type: EXPERIMENTAL
Intervention: 30 min occlusion with a polypropylene chamber
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 30 min occlusion followed by exposure to ambient conditions for 1 h
Number of subjects: 8

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 8
Study: 4927813

Group type: EXPERIMENTAL
Intervention: Metoclopramide (Maxolon)
Number of subjects: 42
Study: 31755906

Group type: EXPERIMENTAL
Intervention: CBT adapted for ASD
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Standard-of-practice CBT
Number of subjects: 145

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 145
Study: 30884170

Group type: EXPERIMENTAL
Intervention: Anakinra 100 mg s.c.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Anakinra 150 mg s.c.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Anakinra 300 mg s.c.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Anakinra 100 mg i.v.
Number of subjects: 32
Study: 28749480

Group type: EXPERIMENTAL
Intervention: Caffeine citrate at 10 mg kg‐1 day‐1, increased to 14 or 20 mg kg‐1 day‐1 BID at 36 weeks PMA
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (53 infants)
Number of subjects: 27
Study: 25516006

Group type: EXPERIMENTAL
Intervention: Ibuprofen/Famotidine combination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 0
Study: 23811648

Group type: EXPERIMENTAL
Intervention: Gingival displacement paste (Expasyl displacement paste)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Gingival retraction cord
Number of subjects: 16
Study: 21816979

Group type: EXPERIMENTAL
Intervention: GFT505 at 80 mg/day
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 19890022

Group type: EXPERIMENTAL
Intervention: Simvastatin (S)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Metformin (M)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Simvastatin plus Metformin (SM)
Number of subjects: 136
Study: 17048576

Group type: EXPERIMENTAL
Intervention: Integrative traditional Chinese and Western medicine (ICWM) - Fufang Huangqi granule and lamivudine for at least 24 weeks
Number of subjects: 115

Group type: COMPARATOR
Intervention: Traditional Chinese medicine (TCM) - Fufang Huangqi granule for at least 24 weeks
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Both groups (ICWM and TCM)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: ICWM
Number of subjects: 115

Group type: COMPARATOR
Intervention: TCM
Number of subjects: 115
Study: 12944147

Group type: EXPERIMENTAL
Intervention: Ultralight wheelchair (UWC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard wheelchair (SWC)
Number of subjects: 60
Study: 11113832

Group type: EXPERIMENTAL
Intervention: Outreach program for young children with cerebral palsy (monthly training of parents with pictorial guidance manual)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Center-based mother-child group (daily attendance)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Health advice (minimal intervention)
Number of subjects: 85
Study: 9095008

Group type: EXPERIMENTAL
Intervention: Peripheral venous lactate (V-LACT)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Arterial lactate (A-LACT)
Number of subjects: 74
Study: 8459913

Group type: EXPERIMENTAL
Intervention: Gadodiamide injection (Gd-DTPA BMA), dosage: 0.1 mmol/kg body weight (0.2 ml/kg)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Gadopentetate dimeglumine (Gd-DTPA), dosage: 0.1 mmol/kg body weight (0.2 ml/kg)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Both contrast media
Number of subjects: 79
Study: 2949196

Group type: EXPERIMENTAL
Intervention: Relaxation training
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: EMG biofeedback training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo condition
Number of subjects: 24
Study: 31083047

Group type: EXPERIMENTAL
Intervention: Low-CHO availability trial (LOW)
Number of subjects: 8

Group type: COMPARATOR
Intervention: High-CHO availability trial (HIGH)
Number of subjects: 8
Study: 29035068

Group type: EXPERIMENTAL
Intervention: Animal-Assisted Therapy (AAT)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (standard therapy sessions)
Number of subjects: 19
Study: 26789124

Group type: EXPERIMENTAL
Intervention: High-Intensity Aerobic Training (HIT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sprint Interval Training (SIT)
Number of subjects: 16
Study: 24674149

Group type: EXPERIMENTAL
Intervention: BCG Connaught
Number of subjects: 142

Group type: COMPARATOR
Intervention: BCG Tice
Number of subjects: 142
Study: 22424252

Group type: EXPERIMENTAL
Intervention: Nonparticipants (defined as English‐speaking patients who did not engage in the call or refused participation)
Number of subjects: 15000

Group type: COMPARATOR
Intervention: Participants (those who engaged in the call and accepted participation)
Number of subjects: 15000
Study: 19403951

Group type: EXPERIMENTAL
Intervention: Yogurt group (Y) consuming 3 servings of yogurt containing vitamin D per day
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Yogurt group (Y)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group maintaining baseline low-dairy-calcium diet
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: All groups (including yogurt, protein, and carbohydrate groups)
Number of subjects: 35
Study: 17299308

Group type: EXPERIMENTAL
Intervention: Memory Structuring Intervention (MSI)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Supportive listening (control)
Number of subjects: 34
Study: 12930254

Group type: EXPERIMENTAL
Intervention: Right atrial linear lesions (RALL)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Non-right atrial linear lesions (NRALL)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Interatrial septum pacing (IASP)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Right atrial appendage pacing (RAAP)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: RALL with IASP
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: RALL with RAAP
Number of subjects: 64

Group type: COMPARATOR
Intervention: NRALL with IASP
Number of subjects: 64

Group type: COMPARATOR
Intervention: NRALL with RAAP
Number of subjects: 64
Study: 11060751

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 0
Study: 9087484

Group type: EXPERIMENTAL
Intervention: dideoxyinosine (ddI) monotherapy
Number of subjects: 23
Study: 8228774

Group type: EXPERIMENTAL
Intervention: Postcard reminder
Number of subjects: 698

Group type: COMPARATOR
Intervention: Questionnaire reminder
Number of subjects: 698

Group type: COMPARATOR
Intervention: Two questionnaires as reminders
Number of subjects: 698

Group type: COMPARATOR
Intervention: All questionnaires
Number of subjects: 698
Study: 3512382

Group type: EXPERIMENTAL
Intervention: Tripotassium dicitrato bismuthate (TDB) tablets
Number of subjects: 80

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 80
Study: 31856902

Group type: EXPERIMENTAL
Intervention: Treatment guided by cerebral oxygenation monitoring
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study: 29443823

Group type: EXPERIMENTAL
Intervention: Progressive aerobic exercise training (3 times per week, 150 min·wk for 16 weeks)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Progressive aerobic exercise training
Number of subjects: 27
Study: 26546784

Group type: EXPERIMENTAL
Intervention: Social stress test
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 79
Study: 24981701

Group type: EXPERIMENTAL
Intervention: Stage tailored intervention (ST)
Number of subjects: 1243

Group type: EXPERIMENTAL
Intervention: Non-stage tailored intervention (NST)
Number of subjects: 1243

Group type: COMPARATOR
Intervention: Assessment only (controls)
Number of subjects: 1243
Study: 22986440

Group type: EXPERIMENTAL
Intervention: linaclotide 290 μg oral once daily
Number of subjects: 800
Study: 19909386

Group type: EXPERIMENTAL
Intervention: Duty-cycled bipolar/unipolar radiofrequency (RF) ablation using 8-10 W delivered simultaneously through 2-10 electrodes
Number of subjects: 88
Study: 18720044

Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose (600 mg) followed by oral iron sulphate (200 mg daily from week 5)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Oral iron sulphate (200 mg daily)
Number of subjects: 128
Study: 15932366

Group type: EXPERIMENTAL
Intervention: Trefoil factor family‐3 enema (10 mg/mL)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 16
Study: 12577194

Group type: EXPERIMENTAL
Intervention: efavirenz + indinavir (EFV+IDV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: efavirenz + zidovudine + lamivudine (EFV+ZDV+3TC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: indinavir + zidovudine + lamivudine (IDV+ZDV+3TC)
Number of subjects: 0
Study: 10583036

Group type: EXPERIMENTAL
Intervention: Perindopril 4-8 mg once daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8904726

Group type: EXPERIMENTAL
Intervention: Anger management training (6-week program including relaxation training, self-statement modification, and role-play assertiveness training)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Anger management training
Number of subjects: 22

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 22
Study: 1806620

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lorazepam
Number of subjects: 0
Study: 6576263

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline or Naloxone (Control)
Number of subjects: 16
Study: 30791771

Group type: EXPERIMENTAL
Intervention: Linaclotide (72 µg, 145 µg, 290 µg)
Number of subjects: 3853

Group type: EXPERIMENTAL
Intervention: Linaclotide (open-label)
Number of subjects: 3853

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3853
Study: 28095924

Group type: EXPERIMENTAL
Intervention: Sonolysis (continual transcranial Doppler monitoring, TCD) using a 2‐MHz diagnostic probe with maximal diagnostic energy
Number of subjects: 704

Group type: COMPARATOR
Intervention: Control (sham procedure)
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Sonolysis (continual transcranial Doppler monitoring, TCD)
Number of subjects: 704
Study: 27354646

Group type: EXPERIMENTAL
Intervention: Docetaxel plus Cisplatin (DP) - Docetaxel 70 mg/m²; Cisplatin 60 mg/m²; administered every 28 days
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Docetaxel plus Cisplatin (DP)
Number of subjects: 64
Study: 25065090

Group type: EXPERIMENTAL
Intervention: Kegel exercise with concentration therapy
Number of subjects: 135

Group type: COMPARATOR
Intervention: Kegel exercise alone
Number of subjects: 135
Study: 23247938

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg/wk
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week (EOW)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg EOW
Number of subjects: 154
Study: 19430082

Group type: EXPERIMENTAL
Intervention: Daily iron-folate (IFA) supplementation (100 mg elemental iron + 0.5 mg folic acid daily for one year)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Twice weekly iron-folate (IFA) supplementation (100 mg elemental iron + 0.5 mg folic acid twice weekly for one year)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Once weekly iron-folate (IFA) supplementation (100 mg elemental iron + 0.5 mg folic acid once weekly for one year)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Control group (no IFA supplementation)
Number of subjects: 163
Study: 17341587

Group type: EXPERIMENTAL
Intervention: 2% lignocaine hydrochloride
Number of subjects: 22

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 22
Study: 12502652

Group type: COMPARATOR
Intervention: No snack (placebo)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Standard snack (two starch + one protein exchange)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Protein snack
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Any snack (standard or protein)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: HS glucose >10 mmol/l
Number of subjects: 15
Study: 10475722

Group type: EXPERIMENTAL
Intervention: Thioridazine (Y: 50 mg; O: 25 mg)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Remoxipride (Y: 100 mg; O: 50 mg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Thioridazine
Number of subjects: 26
Study: 8814044

Group type: EXPERIMENTAL
Intervention: Soy challenge (powdered soy formula in fruit juice)
Number of subjects: 704

Group type: COMPARATOR
Intervention: Placebo (rice or corn flour)
Number of subjects: 704
Study: 2052306

Group type: EXPERIMENTAL
Intervention: Bupivacaine hydrochloride 0.75% (Marcaine)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Balanced salt solution (placebo)
Number of subjects: 50
Study: 7104167

Group type: EXPERIMENTAL
Intervention: Drug with non-linear release (NLR)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Drug with linear release (LR)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: COMPARATOR
Intervention: Drug-free control
Number of subjects: 36
Study: 31825466

Group type: EXPERIMENTAL
Intervention: Mirtazapine 30 mg orally once daily for 24 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 30726969

Group type: EXPERIMENTAL
Intervention: Acipimox 250 mg before oral glucose test
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Acipimox 250 mg before and during metabolic study
Number of subjects: 2
Study: 27821724

Group type: EXPERIMENTAL
Intervention: Autologous CD34+ cells (minimum 10 mol/L±20% cells), N=78
Number of subjects: 161

Group type: COMPARATOR
Intervention: Diluent alone, N=83
Number of subjects: 161
Study: 24670072

Group type: EXPERIMENTAL
Intervention: Worksite social support
Number of subjects: 958
Study: 23980925

Group type: EXPERIMENTAL
Intervention: Guided Family‐Centred Care intervention (n = 74)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Standard care group (n = 60)
Number of subjects: 134
Study: 21601248

Group type: EXPERIMENTAL
Intervention: Tamsulosin plus solifenacin 2.5 mg (TAM+SOL)
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Tamsulosin plus solifenacin 5 mg (TAM+SOL)
Number of subjects: 638

Group type: COMPARATOR
Intervention: Tamsulosin plus placebo (TAM+PBO)
Number of subjects: 638
Study: 18501530

Group type: EXPERIMENTAL
Intervention: IG-IMRT (image-guided intensity-modulated radiotherapy)
Number of subjects: 25

Group type: COMPARATOR
Intervention: IMRT (intensity-modulated radiotherapy)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: IG-IMRT
Number of subjects: 25
Study: 16396628

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Chronic renal failure
Number of subjects: 26
Study: 16236919

Group type: EXPERIMENTAL
Intervention: Smoking reduction with nicotine replacement therapy (nicotine gum and patch), required to reduce smoking by 25% for 2 weeks, 50% for 2 weeks, and 75% during the final 2 weeks.
Number of subjects: 151

Group type: COMPARATOR
Intervention: Ad libitum smoking for 6 weeks (control group).
Number of subjects: 151
Study: 10493476

Group type: EXPERIMENTAL
Intervention: Ultrasound surveillance
Number of subjects: 2257

Group type: COMPARATOR
Intervention: Control of blood pressure and cessation of smoking
Number of subjects: 2257
Study: 8740120

Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg twice daily for 3-5 days)
Number of subjects: 358

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 358
Study: 1833892

Group type: EXPERIMENTAL
Intervention: Enoximone 3 mg/kg orally
Number of subjects: 10
Study: 7042179

Group type: EXPERIMENTAL
Intervention: Pre‐operative radiotherapy combined with daily intravenous fluorouracil during the first 4 days of irradiation followed by surgery (C)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Pre‐operative radiotherapy followed by surgery (R)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Surgery only (S)
Number of subjects: 143
Study: 31863227

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 493

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Nivolumab (CR or PR patients)
Number of subjects: 493
Study: 30266356

Group type: EXPERIMENTAL
Intervention: CGuard™ stent
Number of subjects: 58

Group type: COMPARATOR
Intervention: Wallstent™
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: S100B neurobiomarker
Number of subjects: 58
Study: 30410142

Group type: EXPERIMENTAL
Intervention: Transspinous decompressive laminectomy
Number of subjects: 82
Study: 26851686

Group type: EXPERIMENTAL
Intervention: Plasma disc decompression (PDD)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 177
Study: 24668359

Group type: EXPERIMENTAL
Intervention: Balance Group using 'Wii Fit Plus' in standing
Number of subjects: 30

Group type: COMPARATOR
Intervention: Upper Limb Group using 'Wii Sports/Sports Resort' in sitting
Number of subjects: 30
Study: 22197474

Group type: EXPERIMENTAL
Intervention: Doxepin 6 mg
Number of subjects: 254

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study: 20460116

Group type: EXPERIMENTAL
Intervention: Psychophysically-anchored noxious temperature
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Resting-state PAFs
Number of subjects: 18
Study: 17594219

Group type: EXPERIMENTAL
Intervention: Focused history and physical exam scripts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 15558726

Group type: EXPERIMENTAL
Intervention: Experimental vaginal gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 15114295

Group type: EXPERIMENTAL
Intervention: Acute treatment with 40 mg of ZnSO4 in a single dose
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Chronic treatment with 100 mg ZnSO4 in a single dose daily for 7 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (normal healthy volunteers)
Number of subjects: 20
Study: 10752473

Group type: EXPERIMENTAL
Intervention: Dental-worry disclosure condition (writing about dental worries)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control condition (writing about previous day's activities)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dental-worry disclosure condition
Number of subjects: 80
Study: 8607302

Group type: EXPERIMENTAL
Intervention: 200 micrograms.kg-1 of mivacurium (Group M)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 200 micrograms.kg-1 of mivacurium after 1500 micrograms.kg-1 of succinylcholine (Group SchM)
Number of subjects: 30
Study: 2032325

Group type: EXPERIMENTAL
Intervention: Evacuated phlebotomy tube designed for trace metal analysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ultra-clean polystyrene phlebotomy syringes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard evacuated phlebotomy tubes
Number of subjects: 0
Study: 31094442

Group type: EXPERIMENTAL
Intervention: High sun protection behaviors (wearing protective clothing, avoiding the sun, using sunscreen)
Number of subjects: 313
Study: 28495558

Group type: EXPERIMENTAL
Intervention: Trier Social Stress Test (TSST)
Number of subjects: 50

Group type: COMPARATOR
Intervention: non-stressful placebo version (PTSST)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cortisol levels
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Altruistic decisions
Number of subjects: 50
Study: 26004659

Group type: EXPERIMENTAL
Intervention: MET/CBT+abstinence-based contingency management (CM)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: MET/CBT+CM+Parent Training (PT)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Individual MET/CBT
Number of subjects: 153
Study: 23237616

Group type: EXPERIMENTAL
Intervention: Culturally and family tailored interventions to manage asthma symptoms; specific dosage and duration not applicable as this is qualitative data.
Number of subjects: 0
Study: 21036617

Group type: EXPERIMENTAL
Intervention: Stripping of the posterior knee capsule (PCS)
Number of subjects: 128

Group type: COMPARATOR
Intervention: No stripping of the posterior knee capsule (no-PCS)
Number of subjects: 128
Study: 19142259

Group type: EXPERIMENTAL
Intervention: Soft-Core obturation technique
Number of subjects: 98

Group type: COMPARATOR
Intervention: Cold lateral compaction
Number of subjects: 98
Study: 17695792

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri Tablets (active treatment for 4 weeks)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo (for 4 weeks)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri Tablets (active treatment for 8 weeks)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo (for 8 weeks)
Number of subjects: 73